Bellevue Life Sciences-WRNTOSRHWPreferred / convertible

13F holders, Q2 2025 (June 30)
21holders +1
4new positions
3sold out
2famous investors
$0.17avg. 13F price*

At the end of Q2 2025, 21 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings, up 1 from Q1 2025. 4 opened new positions and 3 sold out. The largest holders were Boothbay Fund Management, LLC ($429K), Toronto Dominion Bank ($26K) and Polar Asset Management Partners Inc. ($21K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).

Company
Bellevue Life Sciences-WRNT
Filed as
OSR HLDGS INC (Q2 2025)
CUSIP
68840D110
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2025: 20Q1 2025Q2 2025: 21Q2 2025Q3 2025: 20Q3 2025Q4 2025: 17Q4 2025Q1 2026: 16Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions4$44K
Exits3$7K

All 13F filers, Q1 2025 → Q2 2025: 821,211 shares bought and 302,963 shares sold, net +518,248 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 21 holders
Boothbay Fund Management, LLC — No change 311,040 $429K
Toronto Dominion Bank — New 489,472 $26K
Polar Asset Management Partners Inc. — No change 360,000 $21K
Atw Spac Management LLC — No change 311,040 $17K
Periscope Capital Inc. — Reduce -26.7% 299,900 $16K
Clear Street LLC — Reduce -0.1% 292,283 $16K
LMR Partners LLP — New 253,001 $13K
Rivernorth Capital Management, LLC — No change 250,000 $13K
Saba Capital Management, L.P. — No change 250,000 $13K
D. E. Shaw & Co. — No change 150,000 $10K
Centiva Capital, LP — No change 100,000 $6K
Wolverine Asset Management LLC — Reduce -2.2% 116,373 $6K
Aristeia Capital, L.L.C. — No change 73,341 $4K
Mint Tower Capital Management B.V. — No change 75,000 $4K
Susquehanna International Group, LLP — New 40,195 $3K
Two Sigma Securities, LLC — Add +27.0% 39,390 $2K
SkyView Investment Advisors, LLC — New 30,000 $2K
Gabelli Funds LLC — No change 27,050 $1K
GABELLI & Co INVESTMENT ADVISERS, INC. — No change 20,800 $1K
Flow Traders U.S. LLC — Add +0.7% 23,422 $1K
Citadel Advisors — Reduce -20.6% 10,025 $647

"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.